Advaxis, Inc. – “3 for 3 on Orphan Drug Requests”

[Accesswire] – PRINCETON, N.J. / ACCESSWIRE / May 5, 2014 / Advaxis, Inc. (NASDAQ: ADXS) today published a new blog post on The Chairman’s Blog, written by the Company’s CEO, Mr. Daniel J. O’Connor. TheChairmansBlog.com … more

View todays social media effects on ADXS

View the latest stocks trending across Twitter. Click to view dashboard

See who Advaxis is hiring next, click here to view